Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
BNGO
$1.50
-4.46%
BNGO
· Bionano Genomics, Inc.
$1.50
-0.07 (-4.46%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has prepared cash flows forecasts which indicate that based on the Company’s expected operating losses and negative cash flows, there is substantial doubt about the Company’s ability to continue as a going concern within twelve months after the date that the unaudited condensed consolidated financial statements for the six months ended June 30, 2026, are issued.”View the 10-Q filed Aug 10, 2026
Market Cap
$20.37M
Shares
11.78M
Volume · Oct 2
384.24K
Avg daily vol (3M)
912.38K
All webcasts
Earnings call · FY2021 Q2
Bionano Genomics, Inc. (BNGO) Q2 2021 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$3.86M
+226.2% YoY
Diluted EPS
-$42.00
Net income
-$18.79M
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 4, 2021 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 4, 2021 · complete as-filed document